3BBLACKBIO3B Blackbio Dx Limited
NSE · Healthcare · Large Cap · Mkt cap ₹4.33T · Vol 26.08M
₹8,003.58
▲ +3.83% today
Fetching live price…
God's Eye forensics
Accounting quality and solvency screens. Anything that can't be computed from available filings data is left blank rather than estimated.
Piotroski F-Score
5/55
5 of 5 financial-health checks passed (4 checks need data this provider doesn't publish).
Altman Z-Score
Insufficient data—
Needs total assets, operating profit and debt — not published for this listing yet.
Beneish (earnings quality)
Insufficient data—
The full manipulation model needs two years of receivables, depreciation and accrual data, which isn't published for this listing.
Scores are free. The criteria-by-criteria breakdown — exactly which checks this company failed — is part of DeepScreen Pro.
Fundamental breakdown — raw ratios are free · fetching live data — showing modeled estimates for now
P/E Ratio (TTM)
Modeled51.5x
Expensive — priced for high growth
Contextual insight — DeepScreen Pro
PEG Ratio
Modeled6.96
Overvalued vs. growth
Contextual insight — DeepScreen Pro
P/S Ratio
Modeled16.22x
Rich sales multiple
Contextual insight — DeepScreen Pro
P/B Ratio
Modeled8.50x
Typical for the sector
Contextual insight — DeepScreen Pro
EV/Revenue
Modeled10.23x
Priced for exceptional growth
Contextual insight — DeepScreen Pro
EV/EBITDA
Modeled24.7x
Fair
Contextual insight — DeepScreen Pro
ROE
Modeled16.5%
Healthy
Contextual insight — DeepScreen Pro
ROA
Modeled7.2%
Low for the sector
Contextual insight — DeepScreen Pro
ROCE
Modeled11.4%
Below cost of capital risk
Contextual insight — DeepScreen Pro
Debt / Equity
Modeled0.95x
Manageable
Contextual insight — DeepScreen Pro
LT Debt / Equity
Modeled0.62x
Moderate long-term leverage
Contextual insight — DeepScreen Pro
Payout Ratio
Modeled24%
Growth company — reinvesting most profit
Contextual insight — DeepScreen Pro
Operating Leverage
Modeled2.06x
Good upside gearing
Contextual insight — DeepScreen Pro
Company financials
- EPS (TTM)
- ₹155.41
- Revenue (TTM)
- ₹266.7B
- Net margin
- 31.5%
- EBITDA margin
- 41.4%
- Earnings growth
- 7.4%
- Dividend yield
- 0.47%
- Payout ratio
- 24%
- Debt / equity
- 0.95x
Live data hasn't loaded yet — figures shown are DeepScreen's modeled estimates.
3BBLACKBIO live news
LIVELoading live headlines…